Innovation Pharmaceuticals Inc (IPIX)

[sunspotter]

“"You can do some nifty pilot studies with $4 million"
Do you mean redoing the OM or pouring dough into an IBD-related study?
Or more in the direction of mildew, mold, fungus, etc.? Or another new direction?”

Whatever they choose.

But instead Leo chose to give it to his Israeli buddies.

If you believe that brilacidin really does have potential as a therapeutic in any of those indications, then the opportunity cost of diverting that $4 million to ‘other purposes’* is utterly enormous.

So either Leo bilked his shareholders or doesn’t really believe brilacidin has such potential.

Or both. #

* ‘other purposes” means add yet more millions to the “let’s steal from the greedy but gullible to inflate the Leo Ehrlich enrichment Fund”

# It’s both.